Spain· ES:1201497001IP1
PHESGO 1200 MG/600 MG SOLUCION INYECTABLE
A medicinal product containing pertuzumab + trastuzumab, registered in Spain by Roche Registration Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- pertuzumab + trastuzumab
- Manufacturer
- Roche Registration Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pertuzumab + trastuzumab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandPhesgoAbacus Medicine A/S
- CanadaPERJETA-HERCEPTINHOFFMANN-LA ROCHE LIMITED
- FrancePHESGO 1200 mg/600 mg, solution injectableROCHE REGISTRATION (ALLEMAGNE)
- United KingdomPhesgo 1200mg/600mg/15ml solution for injection vialsRoche Products Ltd
- IrelandPhesgo 1200 mg/600 mg solution for injectionRoche Registration GmbH
- IcelandPhesgoRoche Registration GmbH*
- NetherlandsPhesgo 1200/600 mg, oplossing voor injectie in injectieflaconRoche Registration GmbH
- NorwayPhesgoRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Phesgo
- Liechtenstein · Phesgo
- Norway · Phesgo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdfddd3d-a4ab-483a-a51b-e2a866a85683 GET /v1/drugs/cdfddd3d-a4ab-483a-a51b-e2a866a85683?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1756394880000}",
"nregistro": "1201497001IP1",
"substance": "pertuzumab + trastuzumab"
}See everything about pertuzumab + trastuzumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.